Costing universal access of highly active antiretroviral therapy in Benin.
about
Economic Burden of HIV/AIDS Upon Households in Nepal: A Critical ReviewCan we spend our way out of the AIDS epidemic? A world halting AIDS model.Exploring the effects of task shifting for HIV through a systems thinking lens: the case of Burkina Faso.The financial burden of morbidity in HIV-infected adults on antiretroviral therapy in Côte d'Ivoire.The cost of providing combined prevention and treatment services, including ART, to female sex workers in Burkina Faso.Scaling up integrated prevention campaigns for global health: costs and cost-effectiveness in 70 countries.First-year lymphocyte T CD4+ response to antiretroviral therapy according to the HIV type in the IeDEA West Africa collaborationIs there scope for cost savings and efficiency gains in HIV services? A systematic review of the evidence from low- and middle-income countries.Barriers to accessing highly active antiretroviral therapy by HIV-positive women attending an antenatal clinic in a regional hospital in western Uganda.Taking ART to scale: determinants of the cost and cost-effectiveness of antiretroviral therapy in 45 clinical sites in Zambia.Married men's perceptions of barriers for HIV-positive pregnant women accessing highly active antiretroviral therapy in rural Uganda.The economic burden of HIV/AIDS on individuals and households in Nepal: a quantitative study.Unit costs for delivery of antiretroviral treatment and prevention of mother-to-child transmission of HIV: a systematic review for low- and middle-income countries.
P2860
Q26766387-CE8C0FB4-9575-4033-B83D-68AF64645453Q30892349-27B5DAA1-FCFB-447D-B730-4081238D072CQ33592053-A28942EF-7F3C-4A64-B92B-9223D80C96E5Q33618976-13416FBA-E5A2-4812-B8AE-BC390CBA41F3Q33783859-D9FFC724-A51C-4096-88EA-9FB05273E35DQ33834900-7EE1EFD5-10AE-49F8-9423-08ADBF76C260Q33891896-67ACD7E5-0CAC-40C8-81CC-417130537932Q34002707-AE478F54-7CDD-4BBE-9FA0-958A432E5EC2Q34198988-7FB7B238-D190-4E9F-8FDF-38540669DC1FQ34532698-B5072215-3CBF-4351-BBB7-B5FF61370585Q36008834-A586E447-A4CD-4585-9BB4-789EA6EF7E20Q36259068-1E88B3C4-6351-4A39-8B10-8C5F492CE640Q37323399-BFF0C794-E9DC-491F-AC42-1B0EA2AAF110
P2860
Costing universal access of highly active antiretroviral therapy in Benin.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Costing universal access of highly active antiretroviral therapy in Benin.
@en
Costing universal access of highly active antiretroviral therapy in Benin.
@nl
type
label
Costing universal access of highly active antiretroviral therapy in Benin.
@en
Costing universal access of highly active antiretroviral therapy in Benin.
@nl
prefLabel
Costing universal access of highly active antiretroviral therapy in Benin.
@en
Costing universal access of highly active antiretroviral therapy in Benin.
@nl
P2093
P2860
P1433
P1476
Costing universal access of highly active antiretroviral therapy in Benin.
@en
P2093
Alain Akonde
David Newlands
Djimon Marcel Zannou
Jules Bashi
Sennen Houessey Hounton
P2860
P304
P356
10.1080/09540120701868303
P50
P577
2008-05-01T00:00:00Z